Alan Brian Collier - Net Worth and Insider Trading

Alan Brian Collier Net Worth

The estimated net worth of Alan Brian Collier is at least $22 dollars as of 2024-06-11. Alan Brian Collier is the CEO of Endonovo Therapeutics Inc and owns about 26,219 shares of Endonovo Therapeutics Inc (ENDV) stock worth over $22. Details can be seen in Alan Brian Collier's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Alan Brian Collier has not made any transactions after 2020-07-01 and currently still holds the listed stock(s).

Transaction Summary of Alan Brian Collier

To

Alan Brian Collier Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alan Brian Collier owns 1 companies in total, including Endonovo Therapeutics Inc (ENDV) .

Click here to see the complete history of Alan Brian Collier’s form 4 insider trades.

Insider Ownership Summary of Alan Brian Collier

Ticker Comapny Transaction Date Type of Owner
ENDV Endonovo Therapeutics Inc 2020-07-01 director & 10 percent owner & CEO

Alan Brian Collier Latest Holdings Summary

Alan Brian Collier currently owns a total of 1 stock. Alan Brian Collier owns 26,219 shares of Endonovo Therapeutics Inc (ENDV) as of July 1, 2020, with a value of $22.

Latest Holdings of Alan Brian Collier

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ENDV Endonovo Therapeutics Inc 2020-07-01 26,219 0.00 22

Holding Weightings of Alan Brian Collier


Alan Brian Collier Form 4 Trading Tracker

According to the SEC Form 4 filings, Alan Brian Collier has made a total of 21 transactions in Endonovo Therapeutics Inc (ENDV) over the past 5 years, including 21 buys and 0 sells. The most-recent trade in Endonovo Therapeutics Inc is the acquisition of 400 shares on July 1, 2020, which cost Alan Brian Collier around $40.

Insider Trading History of Alan Brian Collier

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Alan Brian Collier Trading Performance

GuruFocus tracks the stock performance after each of Alan Brian Collier's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alan Brian Collier is -40.22%. GuruFocus also compares Alan Brian Collier's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alan Brian Collier within 3 months outperforms 2 times out of 57 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Alan Brian Collier's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Alan Brian Collier

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 57 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -4.6 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -5.92 LIMIT LIMIT LIMIT LIMIT LIMIT

Alan Brian Collier Ownership Network

Ownership Network List of Alan Brian Collier

No Data

Ownership Network Relation of Alan Brian Collier

Insider Network Chart

Alan Brian Collier Owned Company Details

What does Endonovo Therapeutics Inc do?

Who are the key executives at Endonovo Therapeutics Inc?

Alan Brian Collier is the director & 10 percent owner & CEO of Endonovo Therapeutics Inc. Other key executives at Endonovo Therapeutics Inc include and 10 percent owner & President Michael Scott Mann .

Endonovo Therapeutics Inc (ENDV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Endonovo Therapeutics Inc (ENDV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Endonovo Therapeutics Inc (ENDV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Endonovo Therapeutics Inc (ENDV)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Endonovo Therapeutics Inc Insider Transactions

No Available Data

Alan Brian Collier Mailing Address

Above is the net worth, insider trading, and ownership report for Alan Brian Collier. You might contact Alan Brian Collier via mailing address: 6320 Canoga Avenue, 15th Floor, Woodland Hills Ca 91367.

Discussions on Alan Brian Collier

No discussions yet.